Items Tagged with 'Pricing'


Group Questions Abbott's Agreement With Thai Government

Despite Abbott Laboratories' recent decision to cut the price of one of its HIV drugs in Thailand, an activist group is questioning the drugmaker's "quid pro quo" approach of lowering drug prices in exchange for halting compulsory licensing. Read More

Part D Negotiation Bill ‘Troubling,’ PhRMA Says

As advocates of bipartisan legislation aimed at lowering Medicare drug prices through direct government negotiation stepped up their efforts to garner support, some in the pharmaceutical industry believe such a policy shift would limit access to certain drugs under the government program.

Read More

BMS Loses $134 Million in Fourth Quarter

Bristol-Myers Squibb (BMS) reported a net loss from continuing operations of $134 million on sales of $4.2 billion in the fourth quarter of 2006, compared with net earnings of $499 million on sales of $5 billion for the same period in 2005.

Read More